Search
beta-Naphthoflavone
go.drugbank.com/drugs/DB06732Experimentalβ-Naphthoflavone, also known as 5,6-benzoflavone, is a potent agonist of the aryl hydrocarbon receptor and induces cytochromes P450 (CYPs) and uridine 5'-diphospho-glucuronosyltransferases (UGTs). … It may be a chemopreventive agent.
PF-05175157
go.drugbank.com/drugs/DB12096InvestigationalPF-05175157 has been used in trials studying the basic science and treatment of Acne Vulgaris, Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes Mellitus Type 2, and Diabetes Mellitus, Type 2, among
SR 140333
go.drugbank.com/drugs/DB05790ExperimentalSR 140333 is tachykinin antagonist which has potential to treat diarrhoea due to food allergy or inflammatory bowel disease.
Carisbamate
go.drugbank.com/drugs/DB12338InvestigationalCarisbamate has been investigated in Alcohol Abuse, Substance Abuse, and Alcohol Dependence.
Fosfructose
go.drugbank.com/drugs/DB13863InvestigationalCategories: Compounds used in a research, industrial, or household settingVantictumab
go.drugbank.com/drugs/DB12956InvestigationalVantictumab has been used in trials studying the treatment of Solid Tumors, Pancreatic Cancer, and Stage IV Pancreatic Cancer.
Rhamnose
go.drugbank.com/drugs/DB02961InvestigationalA methylpentose whose L- isomer is found naturally in many plant glycosides and some gram-negative bacterial lipopolysaccharides. [PubChem]
Acebilustat
go.drugbank.com/drugs/DB15385InvestigationalAcebilustat is under investigation in clinical trial NCT01748838 (Phase 1 Study Assessing the Safety and Tolerability of CTX-4430).
Nifekalant
go.drugbank.com/drugs/DB16008InvestigationalNifekalant is under investigation in clinical trial NCT03855826 (Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection).